News + Filings Holdings
|
VANGUARD GROUP INC
> SUPN
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 6,043,469 | 363,227 | 181,666,679,000 | 181,474,403,000 | $30,060.00 |
| 09/30/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 5,680,242 | 59,794 | 192,276,000 | 29,732,000 | $33.85 |
| 06/30/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 5,620,448 | 81,628 | 162,544,000 | -16,471,000 | $28.92 |
| 03/31/2022 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 5,538,820 | 25,671 | 179,015,000 | 18,251,000 | $32.32 |
| 12/31/2021 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 5,513,149 | 35,406 | 160,764,000 | 14,673,000 | $29.16 |
| 09/30/2021 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 5,477,743 | -6,681 | 146,091,000 | -22,774,000 | $26.67 |
| 06/30/2021 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 5,484,424 | 186,346 | 168,865,000 | 35,565,000 | $30.79 |
| 02/10/2021 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 5,298,078 | 0 | 166,624,553 | 33,324,553 | $31.45 |
| 12/31/2020 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 5,298,078 | 88,338 | 133,300,000 | 24,729,000 | $25.16 |
| 09/30/2020 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 5,209,740 | -212,278 | 108,571,000 | -20,202,000 | $20.84 |
| 06/30/2020 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 5,422,018 | -41,461 | 128,773,000 | 30,485,000 | $23.75 |
| 03/31/2020 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 5,463,479 | 157,590 | 98,288,000 | -27,568,000 | $17.99 |
| 12/31/2019 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 5,305,889 | -76,826 | 125,856,000 | -22,061,000 | $23.72 |
| 09/30/2019 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 5,382,715 | 37,498 | 147,917,000 | -28,956,000 | $27.48 |
| 06/30/2019 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 5,345,217 | 49,676 | 176,873,000 | -8,683,000 | $33.09 |
| 03/31/2019 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 5,295,541 | 57,479 | 185,556,000 | 11,547,000 | $35.04 |
| 12/31/2018 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 5,238,062 | 121,584 | 174,009,000 | -83,605,000 | $33.22 |
| 09/30/2018 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 5,116,478 | 160,765 | 257,614,000 | -38,985,000 | $50.35 |
| 06/30/2018 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 4,955,713 | 170,631 | 296,599,000 | 77,442,000 | $59.85 |
| 03/31/2018 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 4,785,082 | 202,986 | 219,157,000 | 36,560,000 | $45.80 |
| 12/31/2017 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 4,582,096 | 93,032 | 182,597,000 | 3,034,000 | $39.85 |
| 09/30/2017 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 4,489,064 | 988,529 | 179,563,000 | 179,412,127 | $40.00 |
| 06/30/2017 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 3,500,535 | 984,200 | 150,873 | -78,611,127 | $0.04 |
| 03/31/2017 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 2,516,335 | 156,094 | 78,762,000 | 19,166,000 | $31.30 |
| 12/31/2016 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 2,360,241 | 157,698 | 59,596,000 | 5,128,000 | $25.25 |
| 09/30/2016 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 2,202,543 | 2,202,543 | 54,468,000 | 54,468,000 | $24.73 |
| 06/30/2016 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 1,956,476 | 177,648 | 39,854,000 | 12,727,000 | $20.37 |
| 03/31/2016 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 1,778,828 | 1,778,828 | 27,127,000 | 27,127,000 | $15.25 |
| 12/31/2015 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 1,720,166 | 1,720,166 | 23,119,000 | 23,119,000 | $13.44 |
| 09/30/2015 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 0 | -1,305,729 | 0 | -22,171,000 | |
| 06/30/2015 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 1,305,729 | 420,100 | 22,171,000 | 11,463,000 | $16.98 |
| 03/31/2015 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 885,629 | 64,120 | 10,708,000 | 3,889,000 | $12.09 |
| 12/31/2014 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 821,509 | 48,589 | 6,819,000 | 102,000 | $8.30 |
| 09/30/2014 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 772,920 | 772,920 | 6,717,000 | 6,717,000 | $8.69 |
| 06/30/2014 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | 657,835 | 657,835 | 7,203,000 | 7,203,000 | $10.95 |
| << Prev Next >> |
|